• International Journal of Oral Biology
• /
• 제46권2호
• /
• pp.85-93
• /
• 2021

Asarum sieboldii Miq. (Aristolochiaceae) is a perennial herbaceous plant and has been used as traditional medicine for treating diseases, cold, fever, phlegm, allergies, chronic gastritis, and acute toothaches. Also, it has various biological activities, such as antiallergic, antiinflammatory, antinociceptive, and antifungal. However, the anticancer effect of A. sieboldii have been rarely reported, except anticancer effect on lung cancer cell (A549) of water extracts of A. sieboldii. This study investigated the anticancer activity of methanol extracts of A. sieboldii (MeAS) and the underlying mechanism in human FaDu hypopharyngeal squamous carcinoma cells. MeAS inhibited FaDu cells grown dose-dependently without affecting normal cells (L929), as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide and live and dead assay. In addition, concentration of MeAS without cytotoxicity (0.05 and 0.1 mg/mL) inhibited migration and colony formation. Moreover, MeAS treatment significantly induced apoptosis through the proteolytic cleavage of caspase-3, -7, -9, poly (ADP-ribose) polymerase, and downregulation of Bcl-2 and upregulation of Bax in FaDu cells, as determined by fluorescence-activated cell sorting analysis, 4'6-diamidino-2-phenylindole stain, and western blotting. Altogether, these results suggest that MeAS exhibits strong anticancer effects by suppressing the growth of oral cancer cells and the migration and colony formation via caspase- and mitochondrial-dependent apoptotic pathways in human FaDu hypopharyngeal squamous carcinoma cells. Therefore, MeAS can serve as a natural chemotherapeutic for human oral cancer.

• 대한약침학회지
• /
• 제16권3호
• /
• pp.11-22
• /
• 2013

Objectives: The present investigation aimed at examining if post-cancer treatment with a potentized homeopathic drug, Condurango 30C, which is generally used to treat oesophageal cancer, could also show an ameliorating effect through apoptosis induction on lung cancer induced by benzo[a]pyrene (BaP) in white rats (Rattus norvegicus). Methods: Lung cancer was induced after four months by chronic feeding of BaP to rats through gavage at a dose of 50 mg/kg body weight for one month. After four months, the lung-cancer-bearing rats were treated with Condurango 30C for the next one ($5^{th}$), two ($5^{th}-6^{th}$) and three ($5^{th}-7^{th}$) months, respectively, and were sacrificed at the corresponding time-points. The ameliorating effect, if any, after Condurango 30C treatment for the various periods was evaluated by using protocols such as histology, scanning electron microscopy (SEM), annexinV-FITC/PI assay, flow cytometry of the apoptosis marker, DNA fragmentation, reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry, and western blot analyses of lung tissue samples. Results: Striking recovery of lung tissue to a near normal status was noticed after post-cancerous drug treatment, as evidenced by SEM and histology, especially after one and two months of drug treatment. Data from the annexinV-FITC/PI and DNA fragmentation assays revealed that Condurango 30C could induce apoptosis in cancer cells after post-cancer treatment. A critical analysis of signalling cascade, evidenced through a RT-PCR study, demonstrated up-regulation and down-regulation of different pro- and anti-apoptotic genes, respectively, related to a caspase-3-mediated apoptotic pathway, which was especially discernible after one-month and two-month drug treatments. Correspondingly, Western blot and immunohistochemistry studies confirmed the ameliorative potential of Condurango 30C by its ability to down-regulate the elevated epidermal growth factor receptor (EGFR) expression, a hallmark of lung cancer. Conclusion: The overall result validated a positive effect of Condurango 30C in ameliorating lung cancer through caspase-3-mediated apoptosis induction and EGFR down-regulation.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제29권5호
• /
• pp.394-404
• /
• 2007

Oral squamous cell carcinoma is the most prevalent oral cancer, which is characterized by its high metastasis and recurrent rates and poor prognosis. Taxol is an anticancer agent which is microbial products extracted from jew tree. It combines with the tubulin and induces apoptosis by inhibiting mitosis of cell with microtubule stabilization. Recently, it was reported to be effective in various solid tumors, but only very slight effect has been seen in oral squamous cell carcinomas due to its cell-specific potencies. Cyclosporin A is used as immune suppressant and is being applied in anticancer therapy as its mechanism of induction of change of apoptotic process in various cells have been known. In this study, oral squamous cell carcinoma HN22 cell line was used for in vitro experiment and as for the experimental group taxol and cyclosporin A were applied alone and to observe the synergistic effect of apoptosis, Taxol and cyclosporin A were coadministered with different concentration of taxol for comparison. The results were obtained as follow: 1. There was no difference in Bcl-2, Bax, caspase 3, 8, 9 mRNA expression when cyclosprin A or taxol was applied alone to HN 22 cell line. 2. Caspase 3, 9 mRNA expression was prominently increased when cyclosprin A and taxol were applied together to cancer cell. 3. No significant difference was observed when cyclosporin A and taxol($1{\mu}g/ml$ and $3{\mu}g/ml$) were applied together to cancer cell line. 4. No significant difference was seen in Bcl-2, Bax, and caspase 8 mRNA expression in all the groups of in vitro experiments. 5. When cyclosporin A was applied alone in vivo study on the nude mice, histopathologi cal findings was similar to those of the control group. Oral squamous cell carcinoma induced by inoculation of HN 22 cell line was not reduced after treatment of cyclosporin A. 6. When taxol was applied alone, the islands of squamous cell carcinoma still remained, which meant insignificant healing effect. There was a lesser volume increase compared with the cyclosporin A alone. 7. When taxol and cyclosporin A were applied together, the connective tissue and calcification were seen in the histopathologic findings. Oral squamous cell carcinoma was decreased and cancer cell was disappeared. In observing the tumor mass change with time, there was a gradual decreased size and healing features. As the results of the in vitro experiment, it could conclud that only when the two agents are applied together, mitochondria-mediated apoptosis occurred by considerable increase of caspase 3, 9 mRNA expression, irrespectable of the concentration of taxol. In vivo experiment, there was a discrete synergistic effect when the two agents were applied together. But single use of cyclosporin A was not effective in this study. Based on the results of this experiment, if further clinical studies are done, taxol and cyclosporin A could be effectively used in treatment of oral squamous cell carcinomas.

• Journal of Oral Medicine and Pain
• /
• 제38권3호
• /
• pp.221-233
• /
• 2013

담즙산은 지방의 흡수와 콜레스테롤의 항상성을 조절하는 유전자의 전사에 관여하는 필수 콜레스테롤의 생성물이다. 담즙산 합성유도체인 HS-1200이 여러 가지 암세포에서 세포자멸사(apoptosis)를 유도한다는 것이 알려져 있다. 본 연구는 사람혀 편평세포암종세포(SCC25 cells)에서 담즙산 합성유도체인 HS-1200과 대표적인 항암제인 cisplatin의 병용처리 후 세포자멸사 증가효과가 있는지 알아보기 위해 수행하였다. HS-1200과 cisplatin의 병용처리가 단독처리에 비해서 효과적인 세포생존율 감소가 있는지 확인하기 위해서 MTT법을 시행하였고, 세포자멸사의 유도와 증가를 알기 위해서는 DNA 전기영동법, Hoechst 염색법, DNA hypoploidy법 을 사용하였다. 그리고 세포자멸사에 관계하는 단백질의 발현 변화와 세포내에서의 이동을 밝혀내기 위해서 Western blot 분석과 면역형광 염색법을 수행하였다. 더 나아가서 proteasome 활성도와 사립체막 전위 변화를 측정하였다. 본 연구에서는 HS-1200과 cisplatin을 병용처리한 SCC25 세포에서 핵의 농축, DNA분절, MMP와 proteasome 활성도의 감소, Bax의 증가와 Bcl-2의 감소, DNA양의 감소, cytochrome c의 세포질로의 유리, AIF와 DFF40(CAD)의 핵으로의 이동, caspase-9, caspase-7, caspase-3, PARP 그리고 DFF45(ICAD)의 활성화와 같은 다양한 세포자멸사 증거를 보였다. 반면에 상기 물질들에 단독처리 된 SCC25 세포에서는 세포자멸사 현상이 거의 없었다. 24시간 동안 $25{\mu}M$의 HS-1200, $4{\mu}g/ml$의 cisplatin 을 각기 단독처리 한 결과에서는 세포자멸사를 거의 유도하지 못했으나, 병용처리한 결과에는 아주 탁월하고 명확한 세포자멸사의 유도를 보였다. 그러므로 본 실험결과는 HS-1200과 cisplatin 의 병용요법이 사람구강편평세포암종 환자를 위해 새로운 치료전략으로서의 가능성을 보여준다고 생각한다.

• 한국미생물·생명공학회지
• /
• 제28권2호
• /
• pp.87-91
• /
• 2000

미생물로부터 U937 세포주의 etoposide에 유발된 apoptosis 저해물질을 탐색한 결과 곰팡이 F80834 균주를 선발하였다. 균주 배양액으로부터 저해물질을 분리한 후 UV, EIMS, 1H-NMR, 13C-NMR, DEPT 등의 기기분석을 실시한 결과 terrein으로 동정되었다. 이 물질은 $IC_{50}$ $20\mu\textrm{g}/ml$의 농도로 U937 세포주의 etoposide에 의한 caspase 3 유도를 저해하였다. Etoposide에 의한 세포의 사멸도 IC50 $10\mu\textrm{g}/ml$ 농도로 저해하였으며, 동일한 농도 조건에서 단독 처리시 세포 독성을 나타내지 않았다.

• International Journal of Oral Biology
• /
• 제44권2호
• /
• pp.43-49
• /
• 2019

Tannic acid (TA) is a water-soluble polyphenol compound found in various herbal plants. We investigated the chemopreventive effects of TA on FaDu hypopharyngeal squamous carcinoma cells. In an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, TA showed dose-dependent cytotoxicity with a half maximal inhibitory concentration (IC50) of 50 ?M. Cell cycle analysis and immunofluorescence imaging demonstrated that under low-dose ($25{\mu}M$) treatment, FaDu cells were arrested in G2/M phase, and as the dose of TA was increased, apoptosis was induced with the increase of cell population at sub-G1 phase. The expressions of various cyclins, including cyclin D1 and cyclin-dependent kinases (CDK-1 and CDK-2), were down-regulated at low doses of TA, whereas apoptotic effectors such as cleaved caspase 3, cleaved caspase 7, and poly (ADP-ribose) polymerase (PARP) were expressed in a dose-dependent manner in Western blotting. In addition, TA-induced apoptosis of FaDu cells might be mediated by the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase pathway, with the upregulation of p-AKT/p-PKB (phosphorylated protein kinase B) and p-ERK. Overall, our data support the hypothesis that TA is a potential candidate agent for the treatment of hypopharyngeal cancer.

• 한국발생생물학회지:발생과생식
• /
• 제10권1호
• /
• pp.1-7
• /
• 2006

포유류 난포의 폐쇄 과정은 매우 정교한 내분비적 조절작용에 의해 일어나며, 이 과정중에 발생하는 난포 내 과립세포의 퇴화는 핵응축 현상을 동반하는 것으로 알려져 있다. 본 연구는 핵응축 현상과 관련하여 돼지 난소 내 폐쇄난포의 과립세포가 퇴화 시 동반되는 세포 사멸이 아포토시스의 과정에 의해서 일어나는지의 여부와 아포토시스 관련 주요 단백질 분해 효소인 캐스파제-3과 연관된 세포 사멸 기전과 관련이 있는지에 대해서 조사하고자 하였다. 돼지 난소로부터 정상 및 폐쇄난포를 분리하고 이들을 대상으로 조직학적으로 아포토시스 발생 여부를 확인하였고 난포로부터 각각 얻어진 과립세포를 대상으로 하여 아포토시스 과정으로 사멸하는 세포의 형태 및 캐스파제-3의 활성을 관찰 및 측정하였다. 폐쇄 중 돼지 난포 내 과립세포에서 핵의 분절이 흔히 관찰되었고, 유세포 측정기를 이용하여 세포 사멸율을 측정해 본 결과 사멸하는 세포의 수가 폐쇄난포의 과립세포에서 정상난포보다 매우 유의하게 높은 것으로 나타났다. 난포 조직 내 아포토시스 세포는 과립세포에 국한되어 관찰되었으며 협막세포에서는 아포토시스가 관찰되지 않았다. 최종적으로 캐스파제-3의 활성을 정상 및 폐쇄 난포에서 분리한 세포에서 측정해 본 결과 폐쇄난포의 과립세포에서 정상난포보다 유의하게 높은 활성을 보였다. 이와 같은 결과를 종합해 볼 때, 돼지 난포의 폐쇄 중 과립세포의 퇴화는 아포토시스 과정에 의해 일어나며, 캐스파제-3의 활성에 의존적인 것으로 사료된다.

• 예술인문사회 융합 멀티미디어 논문지
• /
• 제7권1호
• /
• pp.395-405
• /
• 2017

와송 유래 에틸아세테이트(EtOAc) 분획물의 인체 폐암세포 A549에 대한 항암활성을 확인하기 위하여 본 연구를 수행하였다. 폐암 세포에 대한 세포 생존율을 측정하기 위하여 MTS assay를 수행한 결과, 농도 의존적으로 폐암세포 성장 억제효과를 보였다. 세포사멸 유도능을 확인하기 위하여 DAPI 핵염색을 통한 직접 육안관찰을 수행한 결과, EtOAc 분획물을 처리한 군에서 핵내 염색질 응축등의 세포사멸 지표가 관찰되었고, Annexin V-FITC를 이용하여 세포막에 노출된 phosphatidylinositol (PS)를 검출한 결과, 농도 의존적으로 초기 세포사멸 및 후기 세포사멸이 증가하였다. 세포사멸의 또다른 지표인 세포주기 억제능을 확인하기 위하여 G2/M기 관련 유전자인 CDK1, 4, cyclin B1, D1의 mRNA 발현정도를 RT-PCR을 이용하여 확인한 결과, 농도의존적으로 mRNA의 발현량이 현저히 감소하였으며, 세포사멸의 직접적 신호전달 표적 단백질인 p53, Bax, Bcl-2 및 pro-caspase-3등의 발현정도를 확인한 결과, p53과 Bax 단백질의 발현은 농도의존적으로 증가하였고, Bcl-2와 pro-caspase-3 단백질의 발현은 시간 및 농도의존적으로 감소하였다.

• 생명과학회지
• /
• 제17권7호통권87호
• /
• pp.948-955
• /
• 2007

생체 면역반응에 중요한 역할을 하는 호중구의 세포사멸은 자연적으로 일어나거나 여러 외부자극에 의한 신호의 전달에 의해 증가하거나 지연된다. 또한 사이토카인과 같은 분화제에 의해 세포사멸이 지연되고 항원 제시 기능을 가진 수지상 세포로 분화되기도 한다. 본 연구에서는 세포사멸 억제제와 사이토카인을 이용한 시스템에서 호중구가 수지상 세포로 분화되는가를 조사하였다. Pancaspase와 serine protease의 억제제인 zVAD-fmk와 AEBSF를 처리하였을 때 호중구의 세포사멸은 현저히 감소되며 AEBSF는 caspase-3와 serine protease활성을 모두 억제하였다. 호중구의 세포사멸을 효과적으로 억제하는 AEBSF와 함께 분화제로 널리 쓰이는 CM-CSF를 같이 처리하여 3일 동안 배양하면 수지상 세포에서 높이 발현되는 CD8O, CD83 및 MHC class ll의 세포표면 마커의 발현이 증가하였다. AEBSF와 CM-CSF를 처리한 호중구를 T-세포와 함께 배양하였을 때 SEB가 존재할 경우 T-세포가 증식되었으며 SEB가 없이도 $IFN{\gamma}$는 생성되었다. 이들 결과들로 부터 serine protease 억제제인 AEBSF를 호중구에 처리하여 세포사멸을 효과적으로 억제하는 것과 수지상 세포로의 분화를 촉진하는 사이토카인인 CM-CSF의작용을 나타내게 하는 조건과는 서로 상호적으로 연관되어 작용할 수 있다는 것을 제시하고 있다.

• Journal of Microbiology and Biotechnology
• /
• 제28권4호
• /
• pp.542-550
• /
• 2018

Heat shock protein 90 (Hsp90) is treated as a molecular therapeutic target for the prevention and treatment of cancer. Geldanamycin (GA) was the first identified natural Hsp90 inhibitor, but hepatotoxicity has limited its clinical application. Nevertheless, a new GA analog (WK-88-1) with the non-benzoquinone skeleton, obtained from genetically engineered Streptomyces hygroscopicus, was found to have anticancer activity against two human breast cancer cell lines. WK-88-1 produced concentration-dependent inhibition of cell proliferation, cell cycle arrest, and apoptosis in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 cell lines. Detailed analysis showed that WK-88-1 downregulated some key cell cycle molecules (CDK1 and cyclin B1) and lead to $G_2/M$ cell cycle arrest. Further studies also showed that WK-88-1 could induce human breast cancer cell apoptosis by downregulating Hsp90 client proteins (Akt, p-Akt, IKK, c-Raf, and Bcl-2), decreasing the ATP level, increasing reactive oxygen species production, and lowering the mitochondrial membrane potential. Meanwhile, we discovered that WK-88-1 significantly decreased the levels of Her-2 and $ER-{\alpha}$ in MCF-7 cells but not in MDA-MB-231 cells. In addition, WK-88-1 significantly increased caspase-3, -8, and -9 activities and the cleavage of PARP in a concentration-dependent manner (with the exception of caspase-3 and PARP in MCF-7 cells). Taken together, our preliminary results suggest that WK-88-1 has the potential to play a role in breast cancer therapy.